VectivBio Holding AG Key Fundamental Indicators
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of VectivBio Holding, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from VectivBio Holding's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting VectivBio Holding's valuation are summarized below:VectivBio Holding AG does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. VectivBio |
Search Suggestions
| VEL | Velocity Financial Llc | Company |
| VEDTX | Vanguard Extended Duration | Mutual Fund |
| VEA | Vanguard FTSE Developed | ETF |
| VET | VET | Cryptocurrency |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, VectivBio Holding AG has a Return On Equity of -0.5692. This is 97.63% lower than that of the Biotechnology sector and 98.44% lower than that of the Health Care industry. The return on equity for all United States stocks is 83.61% higher than that of the company.
VectivBio Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VectivBio Holding's current stock value. Our valuation model uses many indicators to compare VectivBio Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VectivBio Holding competition to find correlations between indicators driving VectivBio Holding's intrinsic value. More Info.VectivBio Holding AG is rated fourth in return on equity category among its peers. It is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value VectivBio Holding by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.VectivBio Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VectivBio Holding's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VectivBio Holding could also be used in its relative valuation, which is a method of valuing VectivBio Holding by comparing valuation metrics of similar companies.VectivBio Holding is currently under evaluation in return on equity category among its peers.
VectivBio Fundamentals
| Return On Equity | -0.57 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (2.95) % | |||
| Current Valuation | 846.2 M | |||
| Shares Outstanding | 62.81 M | |||
| Shares Owned By Insiders | 4.50 % | |||
| Shares Owned By Institutions | 83.80 % | |||
| Number Of Shares Shorted | 77.6 K | |||
| Price To Book | 3.62 X | |||
| Price To Sales | 21.08 X | |||
| Revenue | 27.34 M | |||
| Gross Profit | 27.34 M | |||
| EBITDA | (79.85 M) | |||
| Net Income | (93.73 M) | |||
| Cash And Equivalents | 142.14 M | |||
| Cash Per Share | 3.09 X | |||
| Total Debt | 10.46 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 4.69 X | |||
| Book Value Per Share | 3.40 X | |||
| Cash Flow From Operations | (56.26 M) | |||
| Short Ratio | 0.04 X | |||
| Earnings Per Share | (2.10) X | |||
| Target Price | 18.33 | |||
| Number Of Employees | 10 | |||
| Beta | 0.1 | |||
| Market Capitalization | 1.06 B | |||
| Total Asset | 252.6 M | |||
| Retained Earnings | (207.76 M) | |||
| Working Capital | 201.47 M | |||
| Z Score | 59.56 | |||
| Net Asset | 252.6 M |
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in VectivBio Stock
If you are still planning to invest in VectivBio Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VectivBio Holding's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |